InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SELLAS Life Sciences Group, Inc.

SLS Clue Score19
United States Fiscal year ends December CIK 0001390478
$11.93 +2.40% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $11.93 +33.74% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 29 Dec 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−16.0Net income−17.7Fiscal year 2017Operating income−23.0Net income−23.8Fiscal year 2018Net income−27.7Fiscal year 2019Revenue0.0Operating income−20.0Net income−19.3Fiscal year 2020Revenue1.9Operating income−17.0Net income−16.8EPS, diluted−2.11Fiscal year 2021Revenue7.6 +300.0%Operating income−25.3Net income−20.7EPS, diluted−1.34Fiscal year 2022Revenue1.0 −86.8%Operating income−42.0Net income−41.3EPS, diluted−2.13Fiscal year 2023Revenue0.0 −100.0%Operating income−37.9Net income−37.3EPS, diluted−1.34Fiscal year 2024Operating income−31.5Net income−30.9EPS, diluted−0.50Fiscal year 2025Operating income−28.3Net income−26.9EPS, diluted−0.25
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a 0.0 1.9 7.6 1.0 0.0 n/a n/a
Growth +300.0% −86.8% −100.0%
Operating income −16.0 −23.0 n/a −20.0 −17.0 −25.3 −42.0 −37.9 −31.5 −28.3
Net income −17.7 −23.8 −27.7 −19.3 −16.8 −20.7 −41.3 −37.3 −30.9 −26.9
Growth
EPS, diluted n/a n/a n/a n/a −2.11 −1.34 −2.13 −1.34 −0.50 −0.25

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Operating margin−893.8%Net margin−881.9%Fiscal year 2021Operating margin−332.8%Net margin−272.4%Fiscal year 2022Operating margin−4,195.0%Net margin−4,130.1%Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a −893.8% −332.8% −4,195.0% n/a n/a n/a
Net margin n/a n/a n/a n/a −881.9% −272.4% −4,130.1% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−11.9Capital expenditure−0.0Free cash flow−11.9Fiscal year 2017Operating cash flow−11.0Dividends paid0.0Fiscal year 2018Operating cash flow−30.4Dividends paid−0.5Fiscal year 2019Operating cash flow−17.6Dividends paid0.0Fiscal year 2020Operating cash flow−10.4Fiscal year 2021Operating cash flow−26.0Fiscal year 2022Operating cash flow−23.8Fiscal year 2023Operating cash flow−31.4Fiscal year 2024Operating cash flow−35.4Fiscal year 2025Operating cash flow−28.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −11.9 −11.0 −30.4 −17.6 −10.4 −26.0 −23.8 −31.4 −35.4 −28.4
Capital expenditure −0.0 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free cash flow −11.9 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Growth
Dividends paid n/a 0.0 −0.5 0.0 n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash6.0Total debt16.4Net cash (debt)−10.4Shareholders’ equity−5.0Fiscal year 2017Cash2.3Total debt11.0Net cash (debt)−8.7Shareholders’ equity2.1Debt to equity5.31Fiscal year 2018Cash5.3Total debt0.0Net cash (debt)5.3Shareholders’ equity5.2Debt to equity0.00Fiscal year 2019Cash7.3Shareholders’ equity6.1Fiscal year 2020Cash35.3Shareholders’ equity28.0Fiscal year 2021Cash21.4Shareholders’ equity20.3Fiscal year 2022Cash17.1Shareholders’ equity4.9Fiscal year 2023Cash2.5Shareholders’ equity−8.0Fiscal year 2024Cash13.9Shareholders’ equity9.5Fiscal year 2025Cash71.8Shareholders’ equity70.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 6.0 2.3 5.3 7.3 35.3 21.4 17.1 2.5 13.9 71.8
Total debt 16.4 11.0 0.0 n/a n/a n/a n/a n/a n/a n/a
Net cash (debt) −10.4 −8.7 5.3 n/a n/a n/a n/a n/a n/a n/a
Shareholders’ equity −5.0 2.1 5.2 6.1 28.0 20.3 4.9 −8.0 9.5 70.9
Debt to equity n/a 5.31 0.00 n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−11.9 −11.0 −30.4 −17.6 −10.4 −26.0 −23.8 −31.4 −35.4 −28.4
Growth
0.0 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investment
−0.0 n/a n/a n/a n/a n/a n/a n/a n/a n/a
calc −11.9 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Growth
−0.1 12.2 0.0 n/a n/a 0.0 −4.5 −5.5 0.0 n/a
Financing
16.5 5.5 23.1 19.6 38.4 12.1 24.1 22.3 46.8 86.3
n/a 0.0 −0.5 0.0 n/a n/a n/a n/a n/a n/a

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.